These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 36691582)
1. Measurement instruments for the core outcome set of congenital melanocytic naevi and an assessment of the measurement properties according to COSMIN: a systematic review. Fledderus AC; Boom T; Legemate CM; van der Horst CMAM; Spuls PI JPRAS Open; 2023 Mar; 35():58-75. PubMed ID: 36691582 [TBL] [Abstract][Full Text] [Related]
2. Outcomes and measurement instruments used in congenital melanocytic naevi research: A systematic review. Fledderus AC; Franke CJJ; Eggen CAM; van Etten-Jamaludin FS; van der Horst CMAM; Brinkmann SJH; Spuls PI J Plast Reconstr Aesthet Surg; 2020 Apr; 73(4):703-715. PubMed ID: 31917187 [TBL] [Abstract][Full Text] [Related]
3. Domains and outcomes of the core outcome set of congenital melanocytic naevi for clinical practice and research (the OCOMEN project): part 2. Fledderus AC; Pasmans SGMA; Wolkerstorfer A; Oei W; Etchevers HC; van Kessel MS; van der Horst CMAM; Spuls PI Br J Dermatol; 2021 Nov; 185(5):970-977. PubMed ID: 33959942 [TBL] [Abstract][Full Text] [Related]
4. Development of an international core domain set for medium, large and giant congenital melanocytic naevi as a first step towards a core outcome set for clinical practice and research. Oei W; Fledderus AC; Spuls PI; Eggen CAM; Kottner J; van der Horst CMAM; Wolkerstorfer A; van Kessel MS; Krengel S; Etchevers HC; Korfage IJ; Pasmans SGM Br J Dermatol; 2021 Aug; 185(2):371-379. PubMed ID: 33237568 [TBL] [Abstract][Full Text] [Related]
5. Protocol for the development of core set of domains of the core outcome set for patients with congenital melanocytic naevi (OCOMEN project). Oei W; Fledderus AC; Korfage I; Eggen CAM; van der Horst CMAM; Spuls PI; Brinkmann SJH; Wolkerstorfer A; van Kessel M; Pasmans S J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):267-273. PubMed ID: 31419337 [TBL] [Abstract][Full Text] [Related]
6. How to select outcome measurement instruments for outcomes included in a "Core Outcome Set" - a practical guideline. Prinsen CA; Vohra S; Rose MR; Boers M; Tugwell P; Clarke M; Williamson PR; Terwee CB Trials; 2016 Sep; 17(1):449. PubMed ID: 27618914 [TBL] [Abstract][Full Text] [Related]
7. Neurological signs, symptoms and MRI abnormalities in patients with congenital melanocytic naevi and evaluation of routine MRI-screening: systematic review and meta-analysis. Fledderus AC; Widdershoven AL; Lapid O; Breugem CC; Pasmans SGMA; van der Horst CMAM; Engelen MM; Spuls PI Orphanet J Rare Dis; 2022 Mar; 17(1):95. PubMed ID: 35236387 [TBL] [Abstract][Full Text] [Related]
8. Methods used in the selection of instruments for outcomes included in core outcome sets have improved since the publication of the COSMIN/COMET guideline. Gorst SL; Prinsen CAC; Salcher-Konrad M; Matvienko-Sikar K; Williamson PR; Terwee CB J Clin Epidemiol; 2020 Sep; 125():64-75. PubMed ID: 32470621 [TBL] [Abstract][Full Text] [Related]
9. The measurement of collaboration within healthcare settings: a systematic review of measurement properties of instruments. Walters SJ; Stern C; Robertson-Malt S JBI Database System Rev Implement Rep; 2016 Apr; 14(4):138-97. PubMed ID: 27532315 [TBL] [Abstract][Full Text] [Related]
10. Outcome Measurement Instruments and Evidence-based Recommendations for Measurement of the Pelvic Girdle Pain Core Outcome Set (PGP-COS): A Systematic Review and Consensus Process. Remus A; Lempke AFD; Wuytack F; Smith V J Pain; 2022 Dec; 23(12):2052-2069. PubMed ID: 36115519 [TBL] [Abstract][Full Text] [Related]
11. Outcome measurement instruments for peripheral vascular malformations and an assessment of the measurement properties: a systematic review. Horbach SER; Rongen APM; Elbers RG; van der Horst CMAM; Prinsen CAC; Spuls PI; Qual Life Res; 2020 Jan; 29(1):1-17. PubMed ID: 31549367 [TBL] [Abstract][Full Text] [Related]
12. The COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) and how to select an outcome measurement instrument. Mokkink LB; Prinsen CA; Bouter LM; Vet HC; Terwee CB Braz J Phys Ther; 2016 Jan; 20(2):105-13. PubMed ID: 26786084 [TBL] [Abstract][Full Text] [Related]
13. Evaluating patient-reported outcome measures (PROMs) for bladder cancer: a systematic review using the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist. Mason SJ; Catto JWF; Downing A; Bottomley SE; Glaser AW; Wright P BJU Int; 2018 Nov; 122(5):760-773. PubMed ID: 29726085 [TBL] [Abstract][Full Text] [Related]
14. Assessment of oral health-related quality of life instruments for oral submucous fibrosis: A systematic review using the COnsensus-based Standards for the selection of health Measurement Instruments (COSMIN) checklist. Gondivkar SM; Bhowate RR; Gadbail AR; Sarode SC; Gondivkar RS Oral Oncol; 2019 Jun; 93():39-45. PubMed ID: 31109694 [TBL] [Abstract][Full Text] [Related]
15. Melanoma risk in congenital melanocytic naevi: a systematic review. Krengel S; Hauschild A; Schäfer T Br J Dermatol; 2006 Jul; 155(1):1-8. PubMed ID: 16792745 [TBL] [Abstract][Full Text] [Related]
16. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]